U.S. Capital Markets Stock News

NasdaqGS:CLBK
NasdaqGS:CLBKBanks

A Look At Columbia Financial (CLBK) Valuation After Strong Recent Shareholder Returns

Columbia Financial stock overview Columbia Financial (CLBK) shares have been relatively steady recently, giving investors space to look more closely at the bank’s fundamentals, recent shareholder returns and how the business currently positions itself in the US regional banking sector. See our latest analysis for Columbia Financial. At a share price of $19.90, Columbia Financial has pulled back slightly in the last week but still sits on a 30-day share price return of 3.38% and a year to date...
NYSE:MKC
NYSE:MKCFood

Toms Capital Stake And Unilever Deal Put McCormick’s Valuation In Focus

Toms Capital Investment Management has taken a substantial stake in McCormick (NYSE:MKC). This stake coincides with McCormick's intention to acquire Unilever's food division. Both developments point to potential changes in McCormick's direction, governance, and operations. McCormick is best known for its packaged herbs, spices, sauces, and flavorings, selling into both retail and foodservice channels. The interest in Unilever's food division would widen that reach into a broader packaged...
NasdaqGS:AAPL
NasdaqGS:AAPLTech

Is It Too Late To Consider Apple (AAPL) After A 52% One Year Surge?

If you are wondering whether Apple stock still offers value after its strong run or if you are late to the party, this article will help you compare the current share price with what you are actually getting. Apple shares trade at US$306.31, with the stock down 0.8% over the past week but up 9.3% over the last month and 52.5% over the past year. This naturally raises questions about how much optimism is already reflected in the price. Recent attention on Apple has centered on its position...
NasdaqCM:CLSK
NasdaqCM:CLSKSoftware

Is CleanSpark (CLSK) Quietly Recasting Its Data Center Ambitions With New Finance Leadership?

CleanSpark, Inc. recently appointed Ruben Sahakyan as Senior Vice President of Finance, placing him in charge of capital markets, financial planning and analysis, and company-wide M&A support after more than 15 years across investment banking, equity research, risk management, and asset management. This leadership change comes as CleanSpark reports a transformation toward digital infrastructure and data center development, backed by a large, fully approved power pipeline in Texas and...
NYSE:CDE
NYSE:CDEMetals and Mining

Coeur Mining (CDE) Is Up 9.6% After Record EBITDA, Buyback And Dividend Moves - Has The Bull Case Changed?

In late May 2026, Coeur Mining confirmed the repurchase of 3.99 million shares under its expanded US$750 million buyback program, declared a semiannual dividend payable on June 10, 2026, and reported record adjusted EBITDA with strong free cash flow for the first quarter. Together, these capital returns and financial results highlight management’s emphasis on shareholder payouts alongside operational efficiency, adding a fresh layer to how investors may assess Coeur’s long-term capital...
NasdaqGS:MWH
NasdaqGS:MWHConstruction

A Look At SOLV Energy (MWH) Valuation After Recent Share Price Pullback

Short term stock move SOLV Energy (MWH) has drawn investor attention after its stock declined about 10% over the past week and roughly 15% over the past month, even though year-to-date gains remain positive. See our latest analysis for SOLV Energy. Despite the recent pullback, with a 7 day share price return down 9.9% and a 30 day share price return down 14.8%, the 90 day share price return of 15.1% and year to date share price return of 12.9% suggest that momentum has cooled but not fully...
NasdaqGS:SYRE
NasdaqGS:SYREBiotechs

How Spyre’s Expanded SPY003 Rights and Board Shift Could Reshape Strategic Optionality for SYRE Investors

Spyre Therapeutics recently amended its February 2025 license agreement with Paragon Therapeutics, expanding rights for SPY003 from solely inflammatory bowel disease to all therapeutic, prophylactic, palliative, and diagnostic uses, while keeping dosing restrictions outside inflammatory bowel disease in place until 2028 and 2030. The amendment not only broadens the potential medical applications of SPY003 but also includes terms that could accelerate flexibility if a material transaction or...
NasdaqCM:NAGE
NasdaqCM:NAGEPersonal Products

Is Niagen Bioscience’s (NAGE) NAD+ Research Push Quietly Redefining Its Competitive Moat?

Niagen Bioscience, Inc. recently renamed its ChromaDex External Research Program as the Niagen Research Program and introduced a Trainee Grant Program to support new investigators in exercise performance and recovery, extending backing to more than 175 ongoing NAD+ studies worldwide. This refresh concentrates the company’s scientific identity squarely around its patented Niagen ingredient, underlining how deeply its brand is tied to NAD+ research collaborations. Next, we’ll consider how this...
NasdaqGS:OTEX
NasdaqGS:OTEXSoftware

Does OpenText’s G7-Aligned AI Governance Shift Reframe OTEX’s Long-Term Competitive Moat?

In late May 2026, OpenText announced it had joined the OECD’s Hiroshima AI Process Reporting Framework, aligning its Aviator AI solutions with the G7’s voluntary code for the safe development and deployment of advanced AI across its global data ecosystem. This move places OpenText at the center of international conversations on responsible AI, leveraging its role managing human, machine, and transaction data for more than 120,000 organizations and very large annual B2B commerce flows. We’ll...
NasdaqGS:CRWD
NasdaqGS:CRWDSoftware

A Look At CrowdStrike Holdings's Valuation After Strong Recent Share Price Momentum

CrowdStrike Holdings (CRWD) has been drawing increased attention from investors, with the stock recently closing at US$782.17. The cybersecurity company now carries a market value of about US$186.1b. See our latest analysis for CrowdStrike Holdings. The recent 7% 1 day share price return and 71.7% 1 month share price return point to strong positive momentum, while the 3 year total shareholder return of more than 4x highlights how long term holders have been rewarded. If cybersecurity is on...
NasdaqGS:NVAX
NasdaqGS:NVAXBiotechs

Assessing Novavax (NVAX) Valuation After Recent Share Price Strength And Ongoing Vaccine Commercialization

Recent performance snapshot Novavax (NVAX) has drawn fresh attention after a period where the stock rose around 31% over the past month and about 11% over the past 3 months, in the context of ongoing vaccine commercialization. See our latest analysis for Novavax. That recent 30.7% 1 month share price return builds on a 47.4% year to date share price gain and a 48.7% 1 year total shareholder return, although the 5 year total shareholder return remains sharply negative at 94.6%. If you are...
NYSE:UPS
NYSE:UPSLogistics

Is UPS’s (UPS) Mexico Air Freight Push a Margin Play or a Strategic Shift in Focus?

In late May 2026, UPS announced it had invested nearly US$50 million to expand its North American Air Freight network, adding time-definite heavy freight services to and from Mexico and integrating transportation, brokerage and warehousing for automotive and industrial customers. A particularly interesting element is UPS’s creation of a 300-plus specialist team for automotive and industrial supply chains, signaling a push toward higher-value, industry-specific logistics solutions rather than...
NasdaqGM:OCS
NasdaqGM:OCSPharmaceuticals

Oculis Resets After OCS-01 Setback And Refocuses On Late-Stage Pipeline

Oculis Holding reported that its two Phase 3 DIAMOND trials of OCS-01 in diabetic macular edema did not meet primary or key secondary vision endpoints. The company will not pursue an FDA filing for OCS-01 in this indication and will instead focus resources on other late-stage ophthalmic drug candidates. Shares of NasdaqGM:OCS most recently closed at $14.51. For investors watching NasdaqGM:OCS, the update on OCS-01 represents a major reset for Oculis Holding, since this was a key late-stage...
NYSE:LEU
NYSE:LEUOil and Gas

Is It Too Late To Consider Centrus Energy (LEU) After Its Sharp Multi Year Surge?

Wondering if Centrus Energy at US$189.00 is still offering value, or if most of the easy upside is already behind it? This article focuses squarely on what the current price might mean for you. The stock has been volatile, with a 5.4% gain over the last week, a decline of 8.5% over the past month, down 30.6% year to date, yet still up 51.7% over the past year and showing a very large return over the last 5 years. Recent coverage of Centrus Energy has highlighted ongoing interest in nuclear...
NYSE:AMT
NYSE:AMTSpecialized REITs

Is American Tower (AMT) Pricing Reflecting Its Recent Share Performance And Growth Outlook?

If you are wondering whether American Tower at around US$187.53 is offering value or just adding noise to your portfolio, this article breaks down what the current price might really imply. The stock has recently returned 2.0% over 7 days and 3.3% over 30 days, with a year-to-date return of 7.3% but a decline of 9.2% over the past year and 18.8% over 5 years. Recent coverage has focused on American Tower within the wider real estate investment trust universe, with commentators paying close...
NasdaqGS:CORZ
NasdaqGS:CORZSoftware

Is Core Scientific (CORZ) Quietly Recasting Itself as an AI Infrastructure Landlord?

Core Scientific recently appointed Steve Smith, a veteran data center and digital infrastructure executive and current Zayo Group CEO, to its Board and Nominating and Corporate Governance Committee, while accelerating expansion of five new AI-focused data center sites and pre-funding key equipment amid tight supply conditions. By adding an experienced data center leader and leaning further into long-term AI hosting contracts that now cover structural operating costs, Core Scientific is...
NasdaqCM:AREC
NasdaqCM:ARECOil and Gas

American Resources (AREC) Is Up 19.4% After Swinging To Profit And Hitting High-Profile Conference Circuit

American Resources Corporation recently reported full-year 2025 results, moving from a net loss of US$39.12 million to net income of US$55.41 million, and in June 2026 began presenting at major events such as the 46th Annual William Blair Growth Stock Conference in Chicago. The company’s packed June conference schedule, centered on critical mineral supply chains, energy innovation, and recycling, places its leadership directly before investors, customers, and potential partners at a time...
NYSE:QXO
NYSE:QXOTrade Distributors

QXO’s $17b TopBuild Deal Tests Balance Sheet Strength And Investor Nerves

QXO (NYSE:QXO) is pursuing a $17b acquisition of TopBuild, a move that would make it the second-largest building products distributor in North America. The company has arranged a $3b leveraged loan sale and issued $3b in senior notes to support the transaction. QXO has launched cash tender offers for TopBuild's outstanding debt as part of the deal's financing structure. The merger is drawing legal scrutiny, including shareholder lawsuits and class action inquiries focused on fiduciary duties...
NYSE:EPAM
NYSE:EPAMIT

EPAM Index Shift Reshapes Investor Base And Liquidity Outlook

EPAM Systems (NYSE:EPAM) has been removed from the S&P 500 index. The stock has been added to smaller capitalization indices, including the S&P 600 and S&P 1000. This index reshuffle signals a change in how EPAM is classified within major equity benchmarks. EPAM Systems now trades at $108.76, with the stock down 45.7% year to date and down 36.2% over the past year. Over a 5 year span, the share price is down 77.7%, a steep move that helps explain why NYSE:EPAM is migrating from a large cap...
NYSE:UDR
NYSE:UDRResidential REITs

Is It Time To Reconsider UDR (UDR) After Recent Share Price Weakness?

If you are wondering whether UDR at around US$36.60 offers fair value, a bargain, or a risk you do not need, this article walks through the key signals that matter for you. The stock has been choppy recently, with the price declining 3.7% over the last week, edging up 0.6% over the last month, and sitting slightly down 0.2% year to date, while the 1 year return is also down 7.4%. Over a longer stretch, the stock is up 1.4% over 3 years but down 9.8% over 5 years. This helps frame how recent...
NasdaqGS:LKQ
NasdaqGS:LKQRetail Distributors

Assessing LKQ (LKQ) Valuation After Prolonged Share Price Weakness

Recent share performance and business snapshot LKQ (LKQ) has been under pressure recently, with the stock down 3.9% over the past week, 8.6% over the past month, and 19.1% over the past 3 months. Over longer periods, the stock has declined 13.2% year to date and 32.3% over the past year. The 3 year and 5 year total returns are also negative. This weak share performance contrasts with LKQ’s ongoing role as a large distributor of vehicle replacement parts and accessories across North America...
NasdaqGS:ASTS
NasdaqGS:ASTSTelecom

Is It Too Late To Consider AST SpaceMobile (ASTS) After Its 337.5% One Year Surge?

If you are wondering whether AST SpaceMobile’s recent share price puts it on sale or already prices in the big satellite story, the starting point is to look closely at what the current valuation actually reflects. The stock last closed at US$105.65, with returns of 49.0% over 30 days, 26.6% year to date and 337.5% over 1 year. The 3 year gain is very large and the 5 year return is more than 12x the starting point. That can change how you think about both upside potential and risk. Recent...
NasdaqGS:VNOM
NasdaqGS:VNOMOil and Gas

How Investors May Respond To Viper Energy (VNOM) Expanded Rights To Call Special Shareholder Meetings

At Viper Energy’s 2026 annual meeting on May 19, stockholders approved an amendment allowing investors with at least 20% net long voting power held for one year to call special shareholder meetings, along with other minor governance changes. This shift gives long-term investors a more direct mechanism to influence corporate decisions, potentially affecting how future corporate actions and capital allocation choices are shaped. We’ll now examine how this enhanced shareholder ability to call...
NasdaqGS:HON
NasdaqGS:HONIndustrials

Honeywell Reshapes Portfolio With Aerospace Spin Off And Quantum IPO

Honeywell International (NasdaqGS:HON) is preparing to spin off its Aerospace division into a separate public company, Honeywell Aerospace. This marks a major reshaping of its corporate structure. The remaining business will operate as Honeywell Technologies, with a tighter focus on industrial automation and broader technology solutions. Separately, Honeywell backed quantum computing business Quantinuum has completed an oversubscribed IPO, reflecting investor interest in its quantum platform...